A liability framework for clinical AI: safe harbour for clinicians, liability for makers
Make clear who is responsible when an AI tool contributes to a mistake: protect doctors who use approved tools as intended, and hold makers responsible for the tool's performance.
Liability uncertainty is a major reason hospitals and clinicians do not adopt AI: the clinician may bear responsibility for a tool they cannot inspect. The proposal is legislation or regulatory guidance establishing a safe harbour for clinicians who follow a registered, validated model within its labelled use, coupled with product-liability accountability for developers for performance within the labelled use, and a no-fault compensation scheme for patients harmed by AI errors, as exists for vaccines in several countries.
- AI that is built but not validated or deployed · Thousands of cancer AI models are published; a handful are in clinical use, and fewer have shown they help patients.
Pages like this
not linked directly; found by shared links- IdeaPatients told which AI is used in their care, in plain language
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.
- IdeaRules for retiring cancer AI when performance drops or the standard of care moves
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.
- IdeaMandatory post-market performance reporting for cancer AI
Shares A public registry of every AI model used in cancer care, AI that is built but not validated or deployed.